{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:16:06Z","timestamp":1793121366929,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Righospitalet, Cophenhagen. Denmark"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-M\u00fcllerian hormone (AMH) is released by testicular Sertoli cells and of great importance during fetal male sexual development, but less is known about the role of circulating AMH during adulthood. In vitro studies have shown that vitamin D may induce AMH transcription, but a controlled trial investigating the possible effect of vitamin D on serum AMH has not been conducted in men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single-center, double-blinded, randomized placebo-controlled clinical trial (NCT01304927) conducted in Copenhagen, Denmark. A total of 307 infertile men were included and randomly assigned (1:1) to a single dose of 300,000 IU cholecalciferol followed by 1400 IU cholecalciferol + 500 mg of calcium daily (\n                      <jats:italic>n<\/jats:italic>\n                      = 151) or placebo (\n                      <jats:italic>n<\/jats:italic>\n                      = 156) for 150 days. Difference in serum AMH was a predefined secondary endpoint. Explorative outcomes were associations between serum AMH and gonadal function in infertile men. The primary endpoint was difference in semen quality and has previously been published.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Infertile men in the lowest AMH tertile had significantly lower sperm concentration (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      16 mill\/mL (228%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), sperm count (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      55 million (262%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), motile sperm count (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      28 million (255%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), progressive motile sperm count (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      18 million (300%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), testis size (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      2.7 mL (16%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), serum inhibin B (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      72 pg\/mL (59%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), inhibin B\/FSH ratio (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      48 (145%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), and higher FSH (\u2206\n                      <jats:sub>T3-1<\/jats:sub>\n                      2.6 (38%);\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) than the tertile of infertile men with highest serum AMH. Vitamin D supplementation had no effect on serum AMH compared with placebo treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In infertile men, low serum AMH is associated with severely impaired gonadal function illustrated by poor semen quality and lower testosterone\/LH ratio. Serum AMH in infertile men was not influenced by vitamin D supplementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-02782-1","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:03:08Z","timestamp":1677589388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Low serum anti-M\u00fcllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation"],"prefix":"10.1186","volume":"21","author":[{"given":"Rune","family":"Holt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam Kafai","family":"Yahyavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireen","family":"Kooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Hjorth","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Blomberg Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"2782_CR1","doi-asserted-by":"crossref","unstructured":"Teixeira J, Maheswaran S, Donahoe PK. M\u00fcllerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications. Endocr Rev. 2001;22:657\u201374.","DOI":"10.1210\/edrv.22.5.0445"},{"key":"2782_CR2","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1210\/jc.2010-1207","volume":"95","author":"L Aksglaede","year":"2010","unstructured":"Aksglaede L, S\u00f8rensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, et al. Changes in Anti-M\u00fcllerian Hormone (AMH) throughout the life span: A population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab. 2010;95:5357\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"2782_CR3","doi-asserted-by":"crossref","unstructured":"Matuszczak E, Hermanowicz A, Komarowska M, Debek W. Serum AMH in physiology and pathology of male gonads. Int. J Endocrinol.\u00a02013;2013:6-11.","DOI":"10.1155\/2013\/128907"},{"key":"2782_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/andr.12456","volume":"6","author":"L Aksglaede","year":"2018","unstructured":"Aksglaede L, Olesen IA, Carlsen E, Petersen JH, Juul A, J\u00f8rgensen N. Serum concentration of anti-M\u00fcllerian hormone is not associated with semen quality. Andrology. 2018;6:286\u201392.","journal-title":"Andrology."},{"key":"2782_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrendo.2013.262","volume":"10","author":"MB Jensen","year":"2014","unstructured":"Jensen MB. Vitamin D and male reproduction. Nat Rev Endocrinol. 2014;10:175\u201386.","journal-title":"Nat Rev Endocrinol"},{"key":"2782_CR6","doi-asserted-by":"publisher","first-page":"105589","DOI":"10.1016\/j.jsbmb.2020.105589","volume":"199","author":"R Holt","year":"2020","unstructured":"Holt R, Juel Mortensen L, Harpelunde Poulsen K, Nielsen JE, Frederiksen H, J\u00f8rgensen N, et al. Vitamin D and sex steroid production in men with normal or impaired Leydig cell function. J Steroid Biochem Mol Biol. 2020;199:105589.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2782_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1210\/en.2008-1555","volume":"150","author":"PJ Malloy","year":"2009","unstructured":"Malloy PJ, Peng L, Wang J, Feldman D. Interaction of the vitamin D receptor with a vitamin D response element in the m\u00fcllerian-inhibiting substance (MIS) promoter: Regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology. 2009;150:1580\u20137.","journal-title":"Endocrinology."},{"key":"2782_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12061567","volume":"12","author":"I Moridi","year":"2020","unstructured":"Moridi I, Chen A, Tal O, Tal R. The association between vitamin d and anti-m\u00fcllerian hormone: A systematic review and meta-analysis. Nutrients. 2020;12:1\u201324.","journal-title":"Nutrients."},{"key":"2782_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1210\/jc.2017-01656","volume":"103","author":"M Blomberg Jensen","year":"2018","unstructured":"Blomberg Jensen M, Gerner Lawaetz J, Petersen JH, Juul A, J\u00f8rgensen N. Effects of Vitamin D supplementation on semen quality, reproductive hormones, and live birth rate: A randomized clinical trial. J Clin Endocrinol Metab. 2018;103:870\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"2782_CR10","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/humrep\/dew152","volume":"31","author":"MB Jensen","year":"2016","unstructured":"Jensen MB, Lawaetz JG, Andersson AM, Petersen JH, Nordkap L, Bang AK, et al. Vitamin D deficiency and low ionized calcium are linked with semen quality and sex steroid levels in infertile men. Hum Reprod. 2016;31:1875\u201385.","journal-title":"Hum Reprod"},{"key":"2782_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/andr.12597","volume":"7","author":"A Sansone","year":"2019","unstructured":"Sansone A, Kliesch S, Isidori AM, Schlatt S. AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know? Andrology. 2019;7:131\u20138.","journal-title":"Andrology."},{"key":"2782_CR12","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1210\/clinem\/dgac218","volume":"107","author":"H Benderradji","year":"2022","unstructured":"Benderradji H, Barbotin AL, Leroy-Billiard M, Prasivoravong J, Marcelli F, Decanter C, et al. Defining Reference Ranges for Serum Anti-M\u00fcllerian Hormone on a Large Cohort of Normozoospermic Adult Men Highlights New Potential Physiological Functions of AMH on FSH Secretion and Sperm Motility. J Clin Endocrinol Metab. 2022;107:1878\u201387.","journal-title":"J Clin Endocrinol Metab"},{"key":"2782_CR13","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.fertnstert.2008.02.118","volume":"91","author":"F T\u00fcttelmann","year":"2009","unstructured":"T\u00fcttelmann F, Dykstra N, Themmen APN, Visser JA, Nieschlag E, Simoni M. Anti-M\u00fcllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertil Steril. 2009;91:1812\u20139.","journal-title":"Fertil Steril"},{"key":"2782_CR14","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/humrep\/dew121","volume":"31","author":"JM Andersen","year":"2016","unstructured":"Andersen JM, Herning H, Witczak O, Haugen TB. Anti-M\u00fcllerian hormone in seminal plasma and serum: Association with sperm count and sperm motility. Hum Reprod. 2016;31:1662\u20137.","journal-title":"Hum Reprod"},{"key":"2782_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1472-6483(10)60783-3","volume":"14","author":"M Appasamy","year":"2007","unstructured":"Appasamy M, Muttukrishna S, Pizzey AR, Ozturk O, Groome NP, Serhal P, et al. Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility. Reprod BioMed Online. 2007;14:159\u201365.","journal-title":"Reprod BioMed Online"},{"key":"2782_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/09513590.2010.495433","volume":"27","author":"S El-Halawaty","year":"2011","unstructured":"El-Halawaty S, Azab H, Said T, Bedaiwy M, Amer M, Kamal M, et al. Assessment of male serum anti-Mullerian hormone as a marker of spermatogenesis and ICSI outcome. Gynecol Endocrinol. 2011;27:401\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"2782_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2265.2005.02336.x","volume":"63","author":"A Al-Qahtani","year":"2005","unstructured":"Al-Qahtani A, Muttukrishna S, Appasamy M, Johnst J, Cranfield M, Visser JA, et al. Development of a sensitive enzyme immunoassay for anti-M\u00fcllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol. 2005;63:267\u201373.","journal-title":"Clin Endocrinol"},{"key":"2782_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/09513590701672314","volume":"24","author":"DG Goulis","year":"2008","unstructured":"Goulis DG, Iliadou PK, Tsametis C, Gerou S, Tarlatzis BC, Bontis IN, et al. Serum anti-M\u00fcllerian hormone levels differentiate control from subfertile men but not men with different causes of subfertility. Gynecol Endocrinol. 2008;24:158\u201360.","journal-title":"Gynecol Endocrinol"},{"key":"2782_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.fertnstert.2006.11.110","volume":"88","author":"S Muttukrishna","year":"2007","unstructured":"Muttukrishna S, Yussoff H, Naidu M, Barua J, Arambage K, Suharjono H, et al. Serum anti-M\u00fcllerian hormone and inhibin B in disorders of spermatogenesis. Fertil Steril. 2007;88:516\u20138.","journal-title":"Fertil Steril"},{"key":"2782_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/13685538.2018.1538338","volume":"23","author":"MH Hassan","year":"2021","unstructured":"Hassan MH, Ibrahim HM, El-Taieb MA. 25-Hydroxy cholecalciferol, anti-M\u00fcllerian hormone, and thyroid profiles among infertile men. Aging Male. 2021;23:513\u20139.","journal-title":"Aging Male"},{"key":"2782_CR21","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/humrep\/14.8.2020","volume":"14","author":"P F\u00e9nichel","year":"1999","unstructured":"F\u00e9nichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G. Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod. 1999;14:2020\u20134.","journal-title":"Hum Reprod"},{"key":"2782_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1745-7262.2007.00252.x","volume":"9","author":"T Mostafa","year":"2007","unstructured":"Mostafa T, Amer MK, Abdel-Malak G, Nsser TA, Zohdy W, Ashour S, et al. Seminal plasma anti-M\u00fcllerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE). Asian J Androl. 2007;9:265\u201370.","journal-title":"Asian J Androl"},{"key":"2782_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/humrep\/17.4.968","volume":"17","author":"M Fujisawa","year":"2002","unstructured":"Fujisawa M, Yamasaki T, Okada H, Kamidono S. The significance of anti-M\u00fcllerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod. 2002;17:968\u201370.","journal-title":"Hum Reprod"},{"key":"2782_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.fertnstert.2007.03.032","volume":"89","author":"E Duvilla","year":"2008","unstructured":"Duvilla E, Lejeune H, Trombert-Paviot B, Gentil-Perret A, Tostain J, Levy R. Significance of inhibin B and anti-M\u00fcllerian hormone in seminal plasma: a preliminary study. Fertil Steril. 2008;89:444\u20138.","journal-title":"Fertil Steril"},{"key":"2782_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00786-7","volume":"21","author":"S Aramesh","year":"2021","unstructured":"Aramesh S, Alifarja T, Jannesar R, Ghaffari P, Vanda R, Bazarganipour F. Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after intervention study. BMC Endocr Disord. 2021;21:1\u20135.","journal-title":"BMC Endocr Disord"},{"key":"2782_CR26","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1210\/jc.2012-1213","volume":"97","author":"NA Dennis","year":"2012","unstructured":"Dennis NA, Houghton LA, Jones GT, Van Rij AM, Morgan K, McLennan IS. The level of serum anti-m\u00fcllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab. 2012;97:2450\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"2782_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/and.12972","volume":"50","author":"FF Abdel Hamid","year":"2018","unstructured":"Abdel Hamid FF, Soliman AF, Lashin FES. Circulating 25-hydroxy vitamin D correlates with serum level of anti-M\u00fcllerian hormone in male patients with chronic kidney disease. Andrologia. 2018;50:1\u20139.","journal-title":"Andrologia."},{"key":"2782_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-022-06478-4","volume":"23","author":"SK Yahyavi","year":"2022","unstructured":"Yahyavi SK, Holt R, Juel Mortensen L, Petersen JH, J\u00f8rgensen N, Juul A, et al. Effect of a single-dose denosumab on semen quality in infertile men (the FITMI study): study protocol for a randomized controlled trial. Trials. 2022;23:1\u201310.","journal-title":"Trials."},{"key":"2782_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22734-8","volume":"12","author":"M Blomberg Jensen","year":"2021","unstructured":"Blomberg Jensen M, Andreassen CH, J\u00f8rgensen A, Nielsen JE, Juel Mortensen L, Boisen IM, et al. RANKL regulates male reproductive function. Nat Commun. 2021;12:1\u201315.","journal-title":"Nat Commun"},{"key":"2782_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41416-022-01810-w","volume":"127","author":"CH Andreassen","year":"2022","unstructured":"Andreassen CH, Lorenzen M, Nielsen JE, Kafai Yahyavi S, Toft BG, Ingerslev LR, et al. RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma. Br J Cancer. 2022;127:408\u201321.","journal-title":"Br J Cancer"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02782-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02782-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02782-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:05:28Z","timestamp":1677589528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02782-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2782"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02782-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the Danish Medicines Agency (approval no. 2010-024588-42), the Danish National Committee on Health Research Ethics (approval no. H-4-2010-138), and the Danish Data Protection Agency (approval no. 2010124801) and monitored by the Good Clinical Practice (GCP) Unit, Copenhagen University Hospitals. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}